#2
Ozempic and GLP-1 Agonists as Lifestyle Drugs
Ozempic and GLP-1 agonists spark outrage as Hollywood's weight-loss secret, with ethical debates over drug shortages for diabetic patients. Data shows semaglutide users lose an average of 15% body weight over 68 weeks, per the New England Journal of Medicine (2021).
0
Photos (1)
Comments on "Ozempic and GLP-1 Agonists as Lifestyle Drugs"
Have a take on this ranking?
Comments are how the argument actually happens here. Posting one needs a free account — it takes about a minute.
No comments yet.
The first comment sets the terms of the argument.